{
  "id": "5c61d278e842deac67000005",
  "type": "factoid",
  "question": "Which disease can be classified with the Awaji Criteria?",
  "ideal_answer": "Awaji Criteria are used for amyotrophic lateral sclerosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28444090",
    "http://www.ncbi.nlm.nih.gov/pubmed/20659815",
    "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
    "http://www.ncbi.nlm.nih.gov/pubmed/27212114",
    "http://www.ncbi.nlm.nih.gov/pubmed/21215419",
    "http://www.ncbi.nlm.nih.gov/pubmed/24575803",
    "http://www.ncbi.nlm.nih.gov/pubmed/21940619",
    "http://www.ncbi.nlm.nih.gov/pubmed/26821620",
    "http://www.ncbi.nlm.nih.gov/pubmed/28249004",
    "http://www.ncbi.nlm.nih.gov/pubmed/28631957",
    "http://www.ncbi.nlm.nih.gov/pubmed/24239347",
    "http://www.ncbi.nlm.nih.gov/pubmed/20928911",
    "http://www.ncbi.nlm.nih.gov/pubmed/25843898",
    "http://www.ncbi.nlm.nih.gov/pubmed/29742797",
    "http://www.ncbi.nlm.nih.gov/pubmed/21764635",
    "http://www.ncbi.nlm.nih.gov/pubmed/22277500",
    "http://www.ncbi.nlm.nih.gov/pubmed/22246871",
    "http://www.ncbi.nlm.nih.gov/pubmed/25597926",
    "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
    "http://www.ncbi.nlm.nih.gov/pubmed/28457490",
    "http://www.ncbi.nlm.nih.gov/pubmed/27117334",
    "http://www.ncbi.nlm.nih.gov/pubmed/23261262",
    "http://www.ncbi.nlm.nih.gov/pubmed/24698287",
    "http://www.ncbi.nlm.nih.gov/pubmed/21437935",
    "http://www.ncbi.nlm.nih.gov/pubmed/23407618",
    "http://www.ncbi.nlm.nih.gov/pubmed/27440148"
  ],
  "snippets": [
    {
      "text": "Adoption of the Awaji criteria significantly increased the yield of EMG-positive segments in the cervical (P\u2009<\u20090.0005) and lumbosacral (P\u2009<\u20090.0001) regions, and upgraded 19 patients into the probable category and 1 patient into the definite category.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29742797",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28249004",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "However, previous studies that have assessed the diagnostic sensitivities of the Awaji criteria (AC) and the revised El Escorial criteria (rEEC) in patients with ALS have been inconsistent, most of them were consensual regarding the advantage of Awaji over conventional criteria. Our study sought to compare the roles of AC and rEEC in the diagnosis of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28249004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: Our data demonstrated that the AC exhibited greater diagnostic sensitivity than the rEEC in a Chinese ALS population. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28249004",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To assess the added prognostic value of the aggregated clinical and electrodiagnostic data, which define a given diagnostic category according to the Awaji or revised El Escorial criteria at time of diagnosis in patients with amyotrophic lateral sclerosis (ALS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28631957",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic category according to Awaji (p\u2009<\u20090.0001) or to revised El Escorial (p\u2009=\u20090.0177) criteria, definite ALS according to Awaji (p\u2009<\u20090.0001) or to revised El Escorial (p\u2009=\u20090.0343) and number of regions with LMN involvement (p\u2009<\u20090.0001) were all associated with shorter survival.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28631957",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Methods: This is a cross-sectional and descriptive study including a consecutive series of patients with sporadic amyotrophic lateral sclerosis according to Awaji's criteria. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28444090",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The importance of fasciculation potentials in the diagnosis of ALS led to changes in electrophysiological criteria at Awaji consensus conference. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28457490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Application of Awaji criteria led to a 23% (95% CI, 12% to 33%; I2=84%) increase in the proportion of patients classified as having probable/definite ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE\nTo estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "STUDY SELECTION\nWe searched for studies testing the diagnostic accuracy of the Awaji criteria vs the revised El Escorial criteria in patients referred with suspected ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION\nThe Awaji criteria have a significant clinical impact allowing earlier diagnosis and clinical trial entry in ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 2006, the Awaji criteria for the diagnosis of ALS were proposed, adding two major points to the diagnostic criteria: electromyography is considered equivalent to clinical examination for the identification of LMN signs and fasciculation potentials resume their prominent place in the diagnosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23261262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CLASSIFICATION OF EVIDENCE\nThis study provides Class IV evidence that the Awaji criteria have a higher sensitivity and the same specificity as the rEEC in identifying patients with ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27440148",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CLASSIFICATION OF EVIDENCE This study provides Class IV evidence that the Awaji criteria have a higher sensitivity and the same specificity as the rEEC in identifying patients with ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27440148",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE To assess the sensitivity and specificity of the Awaji and revised El Escorial diagnostic criteria (rEEC) in amyotrophic lateral sclerosis (ALS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27440148",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Awaji Commission recently proposed a modification of the electrodiagnostic criteria for ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION Recently, some authors have claimed that the Awaji criteria (AC) are not always more sensitive than the revised El Escorial criteria (rEEC) in amyotrophic lateral sclerosis (ALS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25597926",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The updated Awaji criteria enhanced the diagnostic sensitivity in limb-onset ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27212114",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND Recently, new electrophysiological ALS criteria incorporating fasciculation potentials (FPs) as evidence for lower motor neuron signs (Awaji Criteria (AC)) was proposed to provide earlier detection of early-stage ALS than revised El Escorial electrophysiological criteria (REEC).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21215419",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Awaji criteria, recently introduced to increase diagnosis sensitivity in amyotrophic lateral sclerosis (ALS), equate the diagnostic significance of neurogenic electrophysiological changes to clinical signs of lower motor neuron dysfunction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24575803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Participants had definite, probable, or possible ALS, as defined by the Awaji criteria; or pure motor disorder with clinical features of upper and lower motor neuron dysfunction in at least one body region, progressing over a 6 month follow-up period; or muscle wasting and weakness for at least 6 months.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25843898",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "New diagnostic criteria for ALS, the Awaji algorithm, reintroduced fasciculations as evidence of acute denervation equivalent to that of fibrillations and positive sharp waves.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21940619",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given that cortical hyperexcitability appears to be an early feature in ALS, the present study assessed the diagnostic utility of a threshold tracking transcranial magnetic stimulation technique as an aid to the research-based Awaji criteria in establishing an earlier diagnosis of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24698287",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The specificity of the both criteria were identical, 99.5%, indicating the number needed to test in order to diagnose one extra case of ALS was 1.8 (1.5-2) for Awaji criteria and 2.4 (2-2.6) for rEEC. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27440148",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our retrospective analysis of patients referred over a 6-month period to the electromyography (EMG) laboratory for suspected motor neuron disease (MND) showed a higher agreement of the Awaji modifications than the Airlie House criteria with the clinical diagnosis of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20928911",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Participants had definite, probable, or possible ALS, as defined by the Awaji criteria; or pure motor disorder with clinical features of upper and lower motor neuron dysfunction in at least one body region, progressing over a 6 month follow-up period; or muscle wasting and weakness for at least 6 months. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25843898",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "<b>OBJECTIVE</b>: To estimate the potential diagnostic added value of the Awaji criteria for diagnosis of a myotrophiclateral sclerosis (ALS), which have been compared with the previously accepted gold standard the revised El Escorial criteria in several studies.<br><b>DATA SOURCES</b>: MEDLINE and Web of Science (until October2011).<br><b>STUDY SELECTION</b>: We searched for studies testing the diagnostic accuracy of the Awaji criteria vs the revised El Escorial criteria in patients referred with suspected ALS.<br><b>DATA EXTRACTION</b>: Evaluation and data extraction of identified studies were done independently.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Application of Awaji criteria led to a 23% (95% CI, 12% to 33%; I2=84%) increase in the proportion of patients classified as having probable/definite ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic accuracy of Awaji criteria was higher in bulbar- than in limb-onset cases.<br><b>CONCLUSION</b>: The Awaji criteria have a significant clinical impact allowing earlier diagnosis and clinical trial entry in ALS.<br>",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using the El Escorial criteria, 51 patients were diagnosed with definite or probable ALS, 14 with probable laboratory-supported ALS, and 28 with possible ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Applying the Awaji recommendations, 66 patients were diagnosed with either definite or probable ALS, and 27 with possible ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20536375",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "amyotrophic lateral sclerosis"
}